- About
- Organization
- Organization Overview
- Dean’s Office
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Research
- Education
- Patient Care
- People
- News
- Events
Ban voted on tobacco industry funds
By UCSF School of Pharmacy Editorial Staff / Thu Mar 6, 2003
UCSF faculty members voted last December 52% to 48% to no longer accept funds from manufacturers of tobacco products or their subsidiaries. Those in favor of the ban argued that UCSF must oppose tobacco industry funding of academia since the health sciences campus is a leader in tobacco control policies and the fight against nicotine addiction and tobacco use prevention. Those opposed to the ban argued that the issue is one of academic freedom in choosing funding sources. For more information, see UCSF Today, UCSF Faculty Vote to Refuse Tobacco Industry Funding, February 27, 2003; and the UCSF Tobacco Control Archives.
Tags
Keywords:
Category:
Sites:
School of Pharmacy, Department of Pharmaceutical Chemistry, Department of Bioengineering and Therapeutic Sciences, Department of Clinical Pharmacy, PharmD Degree Program, BMI, QBC, CCB, PSPG, Bioinformatics, Biophysics
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.
Related news
- UCSF pharmacy faculty advocate for legislation banning tobacco sales in pharmacies
- UCSF School of Pharmacy adopts broad recommendation on tobacco
- WHO plan for global tobacco control contested by US
- Bero’s history of mentorship recognized with Luft and Academic Senate awards
- Wells notes need for academia in drug discovery research and advocacy
